Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03100760 · ClinicalTrials.gov registry record
Urease Breath Test for Rapid Characterization of Pneumonia
A clinical trial of Pneumonia, Bacterial, sponsored by University of New Mexi.
- Completed
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT03100760 is a study of Pneumonia, Bacterial that has completed, run by University of New Mexi. The registered enrollment target is 75 participants, below the 1,338-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03100760, a study of Pneumonia, Bacterial, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1, open label, evaluation of a 13C-urea breath test for the detection of urease-producing bacteria in patient with pneumonia in the emergency department.
Conditions Studied
Interventions
- DEVICE 13C-urea breath test
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-06-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03100760
The ClinicalTrials.gov registry entry for NCT03100760 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,338-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (94% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumonia, Bacterial appearing as the primary indexed condition, and to 1 intervention - of which 13C-urea breath test is the first listed.
NCT03100760 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03100760 about?
NCT03100760 is a clinical study titled "Urease Breath Test for Rapid Characterization of Pneumonia". This is a Phase 1, open label, evaluation of a 13C-urea breath test for the detection of urease-producing bacteria in patient with pneumonia in the emergency department.
What is the current status of trial NCT03100760?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2017-05-01. Estimated completion is 2020-06-04.
What conditions does trial NCT03100760 study?
This clinical trial studies the following conditions: Pneumonia, Bacterial.
What interventions are being tested in trial NCT03100760?
The interventions under investigation include: 13C-urea breath test (DEVICE).
Who is sponsoring clinical trial NCT03100760?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03100760 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia, Bacterial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
ACTIVE NOT RECRUITING · Phase 2
-
Discharge Stewardship in Children's Hospitals
ACTIVE NOT RECRUITING · NA
-
Pneumonia Direct Pilot
COMPLETED
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
COMPLETED · Phase 2
-
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
COMPLETED · Phase 2
-
CTTI Risk Factors for HABP/VABP Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.